Cognitive functions in smoking and non-smoking patients with Check for schizophrenia: A systematic review and meta-analysis of comparative studies.
First author:Wang Yuan-Yuan,Wang Shuo,Zheng Wei,Zhong Bao-Liang
Corresponding author:Xiang Yu-Tao,Li Xiao-Hong
2019-02-01
Journal:Psychiatry Research
Publication type: Research Article
IF(IF): 3.222
PMID: 30583258 Link To Pubmed Full text Download
This systematic review and meta-analysis compared cognitive functions between smoking and non-smoking schizophrenia patients. The PubMed, PsycINFO, EMBASE, Web of Science, and Cochrane Library databases were systematically and independently searched. Basic demographic and clinical characteristics, smoking history and cognitive performance were recorded.
In conclusion, this systematic review and meta-analysis found that smoking schizophrenia patients had worse performance in certain cognitive tasks than non-smoking patients, casting doubts on the validity of the "self-medication hypothesis" that needs to be further examined.
Seven of the 11 studies included in the study, had meta-analyzable data. Compared to non-smoking schizophrenia patients, their smoking counterparts showed significant deficits on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)-immediate memory (n = 739), the RBANS-total score (n = 739) and the Continuous Performance Test-Identical Pairs (n = 157). Two of the 4 studies without meta-analysable data did not report significant group difference in performance on the Wechsler Digit Span Task and the Beck Cognitive Insight Scale, while the other 2 studies found that non-smokers outperformed than smokers in problem solving and visual learning.